Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative

[1]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[2]  J. Cauley,et al.  Clinical Risk Factors for Fractures in Multi‐Ethnic Women: The Women's Health Initiative , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  S. Sereika,et al.  Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  S. Goodin,et al.  Cancer-treatment-induced bone loss, part 1. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  C. Ritenbaugh,et al.  Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer , 2005, Cancer.

[6]  A. M. López,et al.  Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. , 2005, Archives of internal medicine.

[7]  K. Ambrose,et al.  INJURY PREVENTION , 1996, Orthopedic nursing.

[8]  A. LaCroix,et al.  Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials , 2004, Menopause.

[9]  E. Lamont,et al.  Low risk of hip fracture among elderly breast cancer survivors. , 2003, Annals of epidemiology.

[10]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[11]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[12]  W. Willett,et al.  Fracture history and risk of breast and endometrial cancer. , 2001, American journal of epidemiology.

[13]  A. M. Lindsey,et al.  Bone Mineral Density in Postmenopausal Breast Cancer Survivors , 2001, Journal of the American Academy of Nurse Practitioners.

[14]  T. Spector,et al.  A high incidence of vertebral fracture in women with breast cancer , 1999, British Journal of Cancer.

[15]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[16]  P. Delmas,et al.  Bone loss induced by cancer treatment and its management. , 1998, European journal of cancer.

[17]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[18]  D. Grossman,et al.  Injury prevention. Second of two parts. , 1997, The New England journal of medicine.

[19]  S. Cummings,et al.  Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures , 1996 .

[20]  S. Cummings,et al.  Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. , 1996, JAMA.

[21]  T. Powles,et al.  The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  K. P. May,et al.  The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. , 1994, Arthritis and rheumatism.

[23]  S. Cummings,et al.  Risk factors for injurious falls: a prospective study. , 1991, Journal of gerontology.

[24]  H. Adami,et al.  Hip fractures in women with breast cancer. , 1990, American journal of epidemiology.

[25]  R. Prentice.  Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.

[26]  M. Tinetti,et al.  Risk factors for falls among elderly persons living in the community. , 1988, The New England journal of medicine.

[27]  R. Baron,et al.  Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. , 1984, The Journal of bone and joint surgery. American volume.